This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 101/9/910    most recent CIRCRESAHA.107.156786v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rajasingh, J. Articles by Kishore, R. Search for Related Content PubMed PubMed Citation Articles by Rajasingh, J. Articles by Kishore, R. Related Collections Cell biology/structural biology Cell signalling/signal transduction Developmental biology Myogenesis Acute myocardial infarction Other Vascular biology

(Circulation Research. 2007;101:910.)
© 2007 American Heart Association, Inc.

Cellular Biology

STAT3-Dependent Mouse Embryonic Stem Cell Differentiation Into Cardiomyocytes

Analysis of Molecular Signaling and Therapeutic Efficacy of Cardiomyocyte Precommitted mES Transplantation in a Mouse Model of Myocardial Infarction

Johnson Rajasingh, Evelyn Bord, Hiromichi Hamada, Erin Lambers, Gangjian Qin, Douglas W. Losordo, Raj Kishore

From the Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago Ill.

Correspondence to Raj Kishore, PhD, Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, 303 E Chicago Ave, Chicago, IL 60611. E-mail r-kishore{at}northwestern.edu

Pluripotent embryonic stem (ES) cell therapy may be an attractive source for postinfarction myocardial repair and regeneration. However, the specific stimuli and signal pathways that may control ES cell–mediated cardiomyogenesis remains to be completely defined. The aim of the present study was to investigate (1) the effect and underlying signal transduction pathways of leukemia inhibitory factor (LIF) and bone-morphogenic protein-2 (BMP-2)-induced mouse ES cell (mES-D3 line) differentiation into cardiomyocytes (CMC) and (2) the efficacy of CMC precommitted mES cells for functional and anatomical cardiac repair in surgically-induced mouse acute myocardial infarction (AMI) model. Various doses of LIF and BMP-2 and their inhibitors or blocking antibodies were tested for mES differentiation to CMC in vitro. CMC differentiation was assessed by mRNA and protein expression of CMC-specific markers, Connexin-43, CTI, CTT, Mef2c, Tbx5, Nkx2.5, GATA-4, and MHC. LIF and BMP-2 synergistically induced the expression of CMC markers as early as 2 to 4 days in culture. Signaling studies identified STAT3 and MAP kinase (ERK1/2) as specific signaling components of LIF+BMP-2–mediated CMC differentiation. Inhibition of either STAT3 or MAPK activation by specific inhibitors drastically suppressed LIF+BMP-2–mediated CMC differentiation. Moreover, in mouse AMI, transplantation of lentivirus-GFP–transduced, LIF+BMP-2 precommitted mES cells, improved post-MI left ventricular functions, and enhanced capillary density. Transplanted cells engrafted in myocardium and differentiated into CMC and endothelial cells. Our data suggest that LIF and BMP-2 may synergistically enhance CMC differentiation of transplanted stem cells. Thus augmentation of LIF/BMP-2 downstream signaling components or cell type specific precommitment may facilitate the effects of ES cell–based therapies for post-MI myocardial repair and regeneration.

Key Words: ES cells • LIF • STAT3 • BMP-2 • cardiomyocytes

This article has been cited by other articles:

				S. Roy, S. Khanna, S.-R. A. Hussain, S. Biswas, A. Azad, C. Rink, S. Gnyawali, S. Shilo, G. J. Nuovo, and C. K. Sen MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue Cardiovasc Res, April 1, 2009; 82(1): 21 - 29. [Abstract] [Full Text] [PDF]

				D. W. Losordo and R. Kishore A big promise from the very small identification of circulating embryonic stem-like pluripotent cells in patients with acute myocardial infarction. J. Am. Coll. Cardiol., January 6, 2009; 53(1): 10 - 12. [Full Text] [PDF]

				J. Rajasingh, E. Lambers, H. Hamada, E. Bord, T. Thorne, I. Goukassian, P. Krishnamurthy, K. M. Rosen, D. Ahluwalia, Y. Zhu, et al. Cell-Free Embryonic Stem Cell Extract-Mediated Derivation of Multipotent Stem Cells From NIH3T3 Fibroblasts for Functional and Anatomical Ischemic Tissue Repair Circ. Res., June 6, 2008; 102(11): e107 - e117. [Abstract] [Full Text] [PDF]